Shayman_2013_Biochim.Biophys.Acta_1831_602

Reference

Title : Drug induced phospholipidosis: an acquired lysosomal storage disorder - Shayman_2013_Biochim.Biophys.Acta_1831_602
Author(s) : Shayman JA , Abe A
Ref : Biochimica & Biophysica Acta , 1831 :602 , 2013
Abstract :

There is a strong association between lysosome enzyme deficiencies and monogenic disorders resulting in lysosomal storage disease. Of the more than 75 characterized lysosomal proteins, two thirds are directly linked to inherited diseases of metabolism. Only one lysosomal storage disease, Niemann-Pick disease, is associated with impaired phospholipid metabolism. However, other phospholipases are found in the lysosome but remain poorly characterized. A recent exception is lysosomal phospholipase A2 (group XV phospholipase A2). Although no inherited disorder of lysosomal phospholipid metabolism has yet been associated with a loss of function of this lipase, this enzyme may be a target for an acquired form of lysosomal storage, drug induced phospholipidosis. This article is part of a Special Issue entitled Phospholipids and Phospholipid Metabolism.

PubMedSearch : Shayman_2013_Biochim.Biophys.Acta_1831_602
PubMedID: 22960355

Related information

Citations formats

Shayman JA, Abe A (2013)
Drug induced phospholipidosis: an acquired lysosomal storage disorder
Biochimica & Biophysica Acta 1831 :602

Shayman JA, Abe A (2013)
Biochimica & Biophysica Acta 1831 :602